Skip to content
    Asabys Partners logo

    Asabys Partners

    Barcelona, SpainFounded 2018

    Asabys Partners is a Barcelona-based venture capital firm specialized in healthcare and life sciences innovation, including biopharma, medical devices, and digital health. Founded in 2018 by Josep Ll. Sanfeliu and Clara Campàs, the firm invests in companies developing novel solutions for unmet medical needs.

    Deal activity decreased year-over-year (2 deals in the last 12 months vs 9 prior). Average disclosed round size is $68.1M (across 22 rounds with reported amounts).

    Find people at Asabys Partners on Goldilocks AI

    Portfolio

    29

    Fund Size

    $200M

    Top Stage

    Series A

    Last 12 Mo

    2

    Team

    Clara Campàs

    Clara Campàs

    Co-founder and managing partner

    Josep Ll. Sanfeliu

    Josep Ll. Sanfeliu

    Co-founder and managing partner

    Emilio Erazo-Fischer

    Emilio Erazo-Fischer

    Operating Partner

    Guillem Masferrer

    Guillem Masferrer

    Partner

    José María Fernández

    José María Fernández

    Partner

    Montse Vendrell

    Montse Vendrell

    Partner

    Sylvain Sachot

    Sylvain Sachot

    Partner

    Isabel Jimenez

    Isabel Jimenez

    Principal

    Maite Malet

    Maite Malet

    Principal

    Anna Bellmunt

    Anna Bellmunt

    Senior Associate

    Antonio Limatola

    Antonio Limatola

    Senior Associate

    Beatriz Gandarias

    Beatriz Gandarias

    Senior Associate

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    48 investments
    CompanyRoundAmountDate
    Ona Therapeutics logoOna TherapeuticsSeries B$86.6MJun 2026
    OOrivaPre-Seed—Jan 2026
    Qida logoQidaGrowth—Nov 2025
    SafeHeal logoSafeHealSeries C$10MSep 2025
    SpliceBio logoSpliceBioSeries B$135MJun 2025
    SSplice BioSeries B$135MJun 2025
    Deepull logoDeepullSeries C—Apr 2025
    DDEEPULL DIAGNOSTICS, S.L.Series C—Apr 2025
    Augustine Therapeutics logoAugustine TherapeuticsSeries A—Mar 2025
    Quibim logoQuibimSeries A$50MJan 2025
    Augustine Therapeutics logoAugustine TherapeuticsSeries A—Jan 2025
    Anaconda logoAnacondaSeries C$150MJan 2025
    Inbrain Neuroelectronics logoInbrain NeuroelectronicsSeries B$50MOct 2024
    AAgomabSeries D$89MOct 2024
    Augustine Therapeutics logoAugustine TherapeuticsSeries A—Jun 2024
    IInbrainSeries B$50MJan 2024
    Augustine Therapeutics logoAugustine TherapeuticsSeed—Jan 2024
    AAgomabSeries B$100MOct 2023
    AAgomabSeries C$100MOct 2023
    Amelia logoAmeliaGrowth$175MMar 2023
    Orikine Bio logoOrikine BioSeed—Jan 2023
    Osmind, Inc. logoOsmind, Inc.Series B—May 2022
    Sidekick logoSidekickSeries B$55MMay 2022
    SpliceBio logoSpliceBioSeries A—Feb 2022
    Deepull logoDeepullSeries B—Jan 2022
    Page 1 of 2

    Top Co-Investors

    Last updated: 20 October 2026